Download I F H

INDUCED FLAVOUR HYDROLYZED
EQUINE HEMOGLOBIN
PRODUCT PROFILE
SYNTEX S.A.
Luis De Sarro 501 - (B1838DQK) – Luis Guillón – Buenos Aires – Argentina – Tel./Fax: (54 11) 4367-6100 [email protected] –
www.syntexar.com
Brief Introduction
Enzymes use in food industry is a well known and constantly expanding
phenomenon. Enzymes represent a natural choice for food manufacturers
because they are proteins and they accomplish their catalytic task, but they
have already disappeared by the time they are consumed.
Proteolytic enzymes are also used in the manufacturing of stock cubes,
soups, meat flavourings and balanced food obtained from cuts, leather and
scrap byproducts of meat industry, in order to obtain useful meat
proteolyzed in human and animal food industry (1) (2).
So, nothing that does not belong to the start animal tissue is added, having a
meat flavoured hydrolyzed that is not bitter or disagreeable as a result. This
is accomplished at the mercy of specific technologies with proteolytic
enzymes commercialized by important international corporations specialized
in the technology of industrial enzymes development.
In the field of human and animal food industrial elaboration, there is a highly
interesting process: the enzymatic hemoglobin treatment, or best, the blood
globular fraction of animals destined to human consumption.
Enzymatic hydrolysis of blood or erythrocytic package has permitted the
obtaining of valuable products, as well as the industrial exploitation of this
extremely contaminant residue. For example, in the countryside suckling
pigs obtain iron naturally while if raised in corrals, conversely, this does not
happen. Iron injectable supplying is a compulsory supplement to avoid
animal death. The substitution of injectables for oral administration
treatments is desirable but there are no yet feasible alternatives (3).
Enzymatic hemoglobin treatment practiced with industrial enzymes allows
the separation of a globinic and almost colourless hydrolyzed, of a strong
meat flavour and apt for the constitution of animal fodder and food. Liberated
iron, on the other hand, is obtained as a dark and pasty suspension that is
separable through centrifugation. Obtained materials are not of blood aspect
or flavour on the contrary, they are of an attractive and definite meat flavour
of an adjustable composition with different organic iron tenors (Hemo).
SYNTEX S.A.
Luis De Sarro 501 - (B1838DQK) – Luis Guillón – Buenos Aires – Argentina – Tel./Fax: (54 11) 4367-6100 [email protected] –
www.syntexar.com
Use
Even though these materials may be apt for human food fortification and
additivation, Syntex has neither developed application assays in this respect
nor including them in balanced food for animals. However, use of these
products with these ends is documented enough in bibliography (4) (5) (6)
(7) (8) (9).
From these considerations come the following guidelines that can certainly
be expanded by the food science and technology expert, namely:
•
•
•
•
Balanced food inclusion where a strong meat flavour is desirable
(dogs, cats, etc.)
Inasmuch as they are extensively digested hydrolyzed and they
therefore contain a big quantity of free amino acids, they should be
apt for any farm animal nutrition, including poultry.
As it was previously detailed, the presence of amino acids in their
natural “levo” form ensures good bioavailability in animal ´s organism,
giving adequate biostimulation as a result.
Animal species suggested to make use are ovines, swine, poultry,
rabbits, dogs, cats and equines. In addition, in developing regions
fermented and/or cooked blood flour is used to feed sucking pigs
(10). As it was previously explained, the product that is presented
naturally differs conceptual and chemically from blood flour in any of
its forms.
Production
Syntex S.A. has developed and produced hemoglobinic hydrolyzed to
bench-top scale (multigram-kilo lab)
Patent Status
Being methods, products and use perfectly documented, they constitute
prior art and this development is not therefore susceptible of patenting.
Note
Ideas and data previously mentioned must be understood just as guidelines in
applications development and not as a recommendation of use against any patent.
SYNTEX S.A.
Luis De Sarro 501 - (B1838DQK) – Luis Guillón – Buenos Aires – Argentina – Tel./Fax: (54 11) 4367-6100 [email protected] –
www.syntexar.com
Bibliographic Reference
1. Biotimes, N°2, June 1996, 4-5 (Novo Nordisk A/S)
2. Biotimes, N°3, September 1997, 8-9 (Novo Nordisk A/S)
3. Biotimes, N°3, September 1993, 14-15 (Novo Nordisk A/S)
4. Biotimes, N°4, December 1998, 8-9 (Novo Nordisk A/S)
5. Biotimes, N°2, June 2003, pag. 3 (Novo Nordisk A/S)
6. Biotimes, N°1, March 1997, 14-15 (Novo Nordisk A/S)
7. Biotimes, N°3, September 1993, 14-15 (Novo Nordisk A/S)
8. Novo Nordisk, Application Sheet, 2001-06803-02
9. Product Sheet, B717e-GB 1000, May 1996, HCH-Novo Nordisk A/S
10. King’ori, Am et al, Tropical Animal Health Production, 30 [3], 191-6
(1998)
SYNTEX S.A.
Luis De Sarro 501 - (B1838DQK) – Luis Guillón – Buenos Aires – Argentina – Tel./Fax: (54 11) 4367-6100 [email protected] –
www.syntexar.com